Joseph Sassine
josephsassinemd.bsky.social
Joseph Sassine
@josephsassinemd.bsky.social
Transplant ID Faculty & ID Fellowship APD at University of Oklahoma | #TxID | Cancer ID | #ChemalyTeam | Views my own | RT ≠ endorsement | 🇫🇷🇱🇧
Pinned
Excited to launch new tracks in our 2-year ID fellowship program @ou.edu starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care.
Tracks come with option for 12-credit certificates, covered by the program:

medicine.ouhsc.edu/academic-dep...

🧵

#IDSky #TxID
Curriculum
medicine.ouhsc.edu
Also out now in American Journal of Medical Sciences, our review of infectious complications of CAR T and BsAb, led by @ou.edu ID fellow Bradley Dye, a good primer for trainees and faculty alike!

#TxID #IDSky

www.amjmedsci.org/article/S000...
Infectious Complications of Chimeric Antigen Receptor T Cell Therapy and Bispecific Antibodies – A Review
Chimeric antigen receptor (CAR) T cell therapy has shifted the therapeutic landscape of hematological malignancies in the last decade, and bispecific antibodies (BsAb) are an emerging treatment for th...
www.amjmedsci.org
October 18, 2025 at 9:21 AM
Reposted by Joseph Sassine
@bryanpwhite.bsky.social et al: In a cohort (n=127) of OPAT patients on daptomycin 7.4 mg/kg for an average of 37 days, the rate of CK elevation was 11.8% at a median of 13 days (IQR 9-16) supporting weekly lab monitoring on daptomycin for OPAT. doi.org/10.1017/ash....
Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy - Volume 5 Issue 1
doi.org
July 31, 2025 at 11:29 AM
Reposted by Joseph Sassine
This study offers real-world data evaluating the ePlex BCID-FP rapid identification system for yeast and found it was less sensitive than previously reported and infrequently led to de-escalation of antifungals
doi.org/10.1093/jaca...
@josephsassinemd.bsky.social #JACAMRNews #IDSKy
July 15, 2025 at 10:02 AM
ID fellowship applicants, make sure to check out our program @ou.edu:
2 year clinical program - 3 tracks (TxID, hosp epi, trop med) - Path for crit care fellowship - 12 credit certificates in year 2

#TxID #IDSky #MedEd

medicine.ouhsc.edu/academic-dep...
Curriculum
medicine.ouhsc.edu
July 14, 2025 at 3:48 PM
Out now in @jac-amr.bsky.social, our real world analysis of BCID fungal panel for diagnosis of fungemia, led by the great Emily Siegrist - Sensitivity of 94%, lower than anticipated
@bryanpwhite.bsky.social @ritawilson.bsky.social
#IDSky
academic.oup.com/jacamr/artic...
Evaluation of a rapid identification panel for fungemia
Abstract. Bloodstream infections due to yeast are associated with a high mortality rate. There is a lack of data that evaluate the real-world sensitivity o
academic.oup.com
June 27, 2025 at 11:34 AM
And part 2 is out now: How to prevent travel-related infections in the transplant recipient, check it out!
@ritawilson.bsky.social @andhen25.bsky.social
#IDSky #TxID

journals.sagepub.com/doi/full/10....
May 15, 2025 at 3:59 AM
Had a great time in Syracuse presenting Medicine Grand Rounds earlier today on Infections after CAR T at SUNY Upstate and meeting some great ID colleagues there!
#TxID
April 10, 2025 at 8:48 PM
Excited to launch new tracks in our 2-year ID fellowship program @ou.edu starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care.
Tracks come with option for 12-credit certificates, covered by the program:

medicine.ouhsc.edu/academic-dep...

🧵

#IDSky #TxID
Curriculum
medicine.ouhsc.edu
February 11, 2025 at 12:54 PM
How to prevent infections in the increasingly immunocompromised traveler? Part 1 (non-transplant) is out now! Stay tuned for part 2!
@ritawilson.bsky.social @andhen25.bsky.social @ou.edu
#IDSky #TxID

journals.sagepub.com/doi/10.1177/...
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
January 23, 2025 at 12:56 PM
Out now, everything you need to know, that is known and not known, about herpesviruses after CAR T and BsAb, in our review with Dr Emily Siegrist and Dr Roy Chemaly!
@mdanderson.bsky.social @ou.edu
#IDSky #TxID

www.mdpi.com/1999-4915/17...
Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review
In this narrative review, we explore the burden and risk factors of various herpesvirus infections in patients receiving chimeric antigen receptor T-cell (CAR-T) therapy or bispecific antibodies (BsAb...
www.mdpi.com
January 18, 2025 at 2:32 PM
Spoke to @koconews.bsky.social about norovirus, clinical presentation and preventive measures #IDSky

www.koco.com/article/okla...
How Oklahomans can protect themselves from norovirus, or 'stomach bug'
A stomach bug sweeping the country has infected hundreds of patients in its path.
www.koco.com
January 14, 2025 at 12:50 AM
Reposted by Joseph Sassine
T-SPOT.TB performs much better in many immunocompromised populations IMO, but historically was logistically more difficult from CA due to time-sensitive FedEx of samples to Memphis which failed a lot with winter storms. Less an issue now that Quest bought T-SPOT.
Out now in @thetxidjournal.bsky.social!

T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB.

#TxID #IDSky

onlinelibrary.wiley.com/doi/10.1111/...
December 29, 2024 at 5:52 PM
Reposted by Joseph Sassine
T-SPOT resulted in
- fewer indeterminate results (than QFT)
- more “actionable” results (than QFT)

in certain immunocompromised populations #TBSky
Out now in @thetxidjournal.bsky.social!

T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB.

#TxID #IDSky

onlinelibrary.wiley.com/doi/10.1111/...
December 29, 2024 at 1:18 AM
Out now in @thetxidjournal.bsky.social!

T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB.

#TxID #IDSky

onlinelibrary.wiley.com/doi/10.1111/...
December 28, 2024 at 6:11 PM
Reposted by Joseph Sassine
A retrospective cohort study of Gram-negative BSIs in ICU shows fever, lack of source control and time to repeat follow-up blood culture (FUBC) as risk factors for repeat positive FUBC:
https://doi.org/10.1093/jacamr/dlae144
#JACAMRNews @bryanpwhite.bsky.social
Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemia
AbstractObjectives. To evaluate the utility of follow-up blood cultures (FUBCs) for Gram-negative bloodstream infection (BSI) in ICU patients and identify
doi.org
December 27, 2024 at 11:00 AM
Special theme issue in @cmijournal.bsky.social - Infections in immunocompromised hosts, edited by Dr Roy Chemaly, with a series of high yield #TxID reviews, including our review of herpesviruses after allogeneic HCT #IDSky

www.clinicalmicrobiologyandinfection.com/article/S119...
December 18, 2024 at 3:19 PM
Recently spoke with Health IT News about the results of our innovative trial of remote therapeutic monitoring in OPAT, how RTM helped us reduce infection-related readmissions and improve patient adherence to IV ABx #IDSky #OPAT
@ou.edu

www.healthcareitnews.com/news/remote-...
Remote therapeutic monitoring reduces readmissions, academic research shows
The University of Oklahoma College of Medicine did a controlled test and showed the odds of infection-related readmissions were decreased in the RTM group by 76% at 30 days, 80% at 60 days and 68% at ...
www.healthcareitnews.com
December 15, 2024 at 2:29 AM
Check out our most recent work - A large database analysis of viral and fungal infections after CAR T cell therapy, published at @cmijournal.bsky.social, with @andhen25.bsky.social #IDSky #TxID

www.clinicalmicrobiologyandinfection.com/article/S119...
DEFINE_ME
www.clinicalmicrobiologyandinfection.com
December 15, 2024 at 2:27 AM
First post on #IDSky

We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025.

Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with!

DM me for details!

medicine.ouhsc.edu/academic-dep...
Fellowship Opportunities
medicine.ouhsc.edu
December 15, 2024 at 1:29 AM